Nkarta (NKTX) Enterprise Value (2019 - 2026)
Nkarta's (NKTX) quarterly Enterprise Value came in at -$230.4 million in Q1 2026, up 13.21% year-on-year from -$203.5 million in Q1 2025, and up 16.6% quarter-over-quarter from -$276.3 million in Q4 2025.
Nkarta (NKTX) Enterprise Value (2019 - 2026) Analysis & Trends
Nkarta's Enterprise Value history runs 8 years deep, the most recent figure standing at -$230.4 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 13.21% year-over-year to -$230.4 million in Q1 2026; TTM through Mar 2026 was -$230.4 million, a 13.21% increase from a year earlier, with the FY2025 full-year figure at -$276.3 million, down 3.34% from the prior year.
- Enterprise Value grew to -$230.4 million in Q1 2026 per NKTX's latest filing, from -$276.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$217.0 million in Q1 2022 and bottomed at -$437.4 million in Q1 2024.
- The 5-year median for Enterprise Value is -$282.3 million (2025), against an average of -$303.5 million.
- Across the five-year window, Enterprise Value sank 52.25% in 2022 and soared 39.3% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$352.1 million in 2022, then advanced by 29.52% to -$248.2 million in 2023, then dropped by 7.72% to -$267.4 million in 2024, then declined by 3.34% to -$276.3 million in 2025, then rose by 16.6% to -$230.4 million in 2026.
- Per Business Quant, the three latest NKTX Enterprise Value figures stand at -$230.4 million (Q1 2026), -$276.3 million (Q4 2025), and -$282.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | -230.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -230.43 Mn |
| Dec 31, 2025 | -276.28 Mn |
| Sep 30, 2025 | -282.33 Mn |
| Jun 30, 2025 | -289.69 Mn |
| Mar 31, 2025 | -265.51 Mn |
| Dec 31, 2024 | -267.35 Mn |
| Sep 30, 2024 | -283.06 Mn |
| Jun 30, 2024 | -324.82 Mn |
| Mar 31, 2024 | -437.39 Mn |
| Dec 31, 2023 | -248.19 Mn |
| Sep 30, 2023 | -275.61 Mn |
| Jun 30, 2023 | -280.75 Mn |
| Mar 31, 2023 | -323.34 Mn |
| Dec 31, 2022 | -352.14 Mn |
| Sep 30, 2022 | -392.36 Mn |
| Jun 30, 2022 | -412.95 Mn |
| Mar 31, 2022 | -216.96 Mn |
| Dec 31, 2021 | -238.09 Mn |
| Sep 30, 2021 | -257.70 Mn |
| Jun 30, 2021 | -279.80 Mn |